SUBDUE‐3: SUB‐urothelial DUrvalumab‐ 89 zirconium injEction; a phase 0 biodistribution study protocol

British Journal of Urology 2026 Open access

Read full text
Authors: K.G. Keane, Richard Gauci, Roslyn J. Francis, Andrew M. Scott, Cynthia Hawks, Andrisha–Jade Inderjeeth, I Stephen Davis, J. H. Mark Lim, Andrew David Redfern, Dickon Hayne
DOI: 10.1111/bju.70153
Cited by: 0
References: 9

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Radiopharmaceutical Chemistry and Applications Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
British Journal of Urology
Volume
138
Issue
S2
Pages
S26–S29
Publication date
11 February 2026
Language
EN